The Clinical Decision Support Systems Market was valued at USD 5.79 billion in 2024, and is projected to reach USD 10.71 billion by 2030, rising at a CAGR of 11.00%. Government initiatives aimed at promoting the adoption and integration of Clinical Decision Support Systems (CDSS) are expected to drive market growth by incentivizing hospitals and healthcare organizations to deploy such solutions. For example, in April 2023, the U.S. Department of Health and Human Services (HHS) revised certification program rules to encourage greater utilization of clinical decision support tools. Furthermore, advancements in AI and cloud-based CDSS technologies are projected to accelerate market expansion. The implementation of cloud-based computing to enhance CDSS platforms and database management is also anticipated to positively influence market growth in the forecast period.
During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.
Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.
Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions.
This product will be delivered within 1-3 business days.
During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.
Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.
Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions.
Clinical Decision Support Systems Market Report Highlights
- Researchers are integrating AI into Clinical Decision Support Systems (CDSS) to process vast data to recommend treatment strategies, highlight potential issues, streamline operations, and support healthcare professionals.
- Standalone CDSS held the largest market share of 30.7% in 2024, because it is widely adopted for its low cost and simplicity. They don't require standardization or extensive clinical expertise and can operate without real patient data.
- Drug allergy alerts accounted for the largest market share of 25.7% in 2024. Several people have allergies to specific drugs, so it is important to have systems that provide allergy alerts
- CDSS services held the largest market share of 42.3% in 2024, as it offers implementation, training, support, customization, and consulting services to help healthcare organizations maximize the value of CDSS software and optimize clinical decision-making
- On-premise segment in delivery mode dominated the market with the largest share of 41.9% in 2024. On-premise CDSS solutions offer flexibility for customization and integration with existing healthcare systems and workflows, catering to specific organizational needs.
- The Clinical Decision Support Systems market in North America accounted for a share of 25.3% of the global revenue in 2024. North American consumers tend to prioritize Clinical Decision Support Systems that reflects current trends, personal style, and individual expression
- North America clinical decision support systems market dominated the global market with over 43.10% revenue share in 2024. This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Clinical Decision Support Systems Market Variables, Trends & Scope
Chapter 4. Clinical Decision Support Systems Market: Product Estimates & Trend Analysis
Chapter 5. Clinical Decision Support Systems Market: Application Estimates & Trend Analysis
Chapter 6. Clinical Decision Support Systems Market: Delivery Mode Estimates & Trend Analysis
Chapter 7. Clinical Decision Support Systems Market: Component Estimates & Trend Analysis
Chapter 8. Clinical Decision Support Systems Market: Regional Estimates & Trend Analysis, By Type, By Application, By Delivery Mode, By Component
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Clinical Decision Support Systems market report include:- McKesson Corporation
- Cerner Corporation
- Siemens Healthineers GmbH
- Allscripts Healthcare, LLC
- athenahealth, Inc.
- NextGen Healthcare Inc.
- Koninklijke Philips N.V. (Royal Philips)
- IBM Corporation
- Agfa-Gevaert Group
- Wolters Kluwer N.V.
- Becton, Dickinson and Company
- Cabot Technology Solutions
- GE HealthCare
- Nordic
- BeeKeeperAI
- BSCO Industries, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 135 |
Published | May 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 5.79 Billion |
Forecasted Market Value ( USD | $ 10.71 Billion |
Compound Annual Growth Rate | 11.0% |
Regions Covered | Global |
No. of Companies Mentioned | 17 |